Benitec Biopharma Inc.
Financial highlights
| Metric | FY 06/30/26 | FY 06/30/25 | FY 06/30/24 | FY 06/30/23 | FY 06/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | $0.0 | $0.1 | $0.1 |
| Operating income | -$51.2 | -$41.8 | -$22.5 | -$19.1 | -$17.9 |
| Net income | -$45.5 | -$37.9 | -$21.8 | -$19.6 | -$18.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$16.6 | -$23.6 | -$19.6 | -$18.0 | -$15.9 |
Shares outstanding 34.9M · Free float 42.5%
Annual filing data through FY ended June 30, 2026; float as of October 5, 2026.